Intimation Of Re-Appointment Of Executive Directors Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

Please see annexed enclosure.

Intimation Of Grant Of Stock Options To The Eligible Employees

Please see annexed enclosure.

Announcement under Regulation 30 (LODR)-Acquisition

Please see annexed enclosure.

Corrigendum To Intimation Of Grant Of Stock Options To The Eligible Employees Dated 28.03.2025

Please see annexed enclosure.

Closure of Trading Window

Please see annexed enclosure.

Laurus Labs Concludes Successful USFDA Audit For API Manufacturing Facility At Hyderabad

Please see annexed enclosure.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please see annexed enclosure.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please see annexed enclosure.

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Please see annexed notice of postal ballot.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mirae Asset Mutual Fund

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat

Please see annexed enclosure.

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat

Please see annexed enclosure.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mirae Asset Mutual Fund

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Please see annexed enclosure.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please see annexed enclosure

Unaudited Financial Results For The Quarter Ended June 30 2024

Please see annexed enclosure

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor presentation for the quarter ended June 30 2024

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Please see annexed enclosure.

Announcement under Regulation 30 (LODR)-Change in Directorate

Please see annexed enclosure

Board Meeting Outcome for Outcome Of The Board Meeting Held On 25Th July 2024

Please see annexed enclosure

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release for the Quarter ended June 30 2024

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Please find enclosed the Q1 FY 25 Earnings conference call invite for the call scheduled on July 25 2023 at 05.00 PM (IST).

Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30 2

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday July 25 2024... More> ter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2024.<Less

Update On Our Disclosure Dated April 25 2024 Regarding The Appointment Of Directors.

Please see annexed enclosure.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June30 2024

Shareholder Meeting / Postal Ballot-Scrutinizers Report

Please find enclosed annexure.

Shareholder Meeting / Postal Ballot-Outcome of AGM

Please find enclosed the summary of the proceedings of the 19th Annual General Meeting held on July 11 2024.

Disclosure Under Regulation 30 Of SEBI LODR

Reg. 30 disclosure

Closure of Trading Window

Closure of Trading Window from July 01 2024

Announcement under Regulation 30 (LODR)-Credit Rating

Update on Credit rating

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advt.

Reg. 34 (1) Annual Report.

Annual Report FY 2023-24

Business Responsibility and Sustainability Reporting (BRSR)

BRSR FY 2023-24

Notice Of The 19Th AGM Of The Company Will Be Held On July 11 2024

Notice of 19th AGM

Announcement under Regulation 30 (LODR)-Credit Rating

update on credit rating

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advt.

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mirae Asset Mutual Fund

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Investor Meetings on June 12-13 2024

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

B&K Securities 14th Annual Conference - Trinity India 2024 on May 30 2024

Reply To The Clarification Sought By The Exchanges

Reply letter is attached

Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report FY 2024

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of ESOPs

Clarification sought from Laurus Labs Ltd

The Exchange has sought Clarification from Laurus Labs Ltd with reference to the media report appearing on https://timesofindia.indiatimes.com dated May 25 2024 (Link:... More> ons/articleshow/110408394.cms) titled Laurus Labs gets USFDA letter for CGMP violations.The reply is awaited.<Less

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Q4 FY 24 Concall transcript

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Audio Recording of Q4 FY 24 Earnings call

Book Closure For AGM

Book Closure for AGM

Corporate Action-Board approves Dividend

interim dividend

Announcement under Regulation 30 (LODR)-Change in Directorate

Changes in Directorate of the Company

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor PPT

Board Meeting Outcome for Outcome Of The Board Meeting Dated April 25 2024

OUTCOME

Financials For Q4 FY 24

Q4 Financials

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat

USFDA Inspection

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Q4 FY 24 Earnings call on April 25 2024 at 1700 Hrs.

Board Meeting Intimation for Approval Of Audited Financial Results For FY 24 And Declaration Of 2Nd

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Audited Financial Results for FY 24 and Declaration of 2nd interim Dividend

Announcement under Regulation 30 (LODR)-Updates on Joint Venture

KRKA PHARMA PRIVATE LIMITED a Joint Venture Company got Incorporated

Compliance Certificate For March 2024

7(3) certificate

Certificate Under Reg. 40(9) Of SEBI LODR

40(9) CERTIFICATE

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

74(5) certificate

Closure of Trading Window

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Acquisition

Further equity infusion in Laurus Synthesis Private Limited a wholly owned subsidiary

Announcement under Regulation 30 (LODR)-Updates on Acquisition

ImmunoACT update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst/Investor Meeting on February 192024 and February 202024

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript for Q3 FY24 Earnings call hosted on January 24 2024

Announcement under Regulation 30 (LODR)-Press Release / Media Release

PRESS RELEASE

Announcement under Regulation 30 (LODR)-Joint Venture

Laurus Labs enters into JV Agreement with KRKA

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Audio recording of the earnings call hosted on January 24 2024

Announcement under Regulation 30 (LODR)-Investor Presentation

investor PPT

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release

Financial Results For Q3 FY 2024

Financial results for Q3 FY 2024

Grant Of Stock Options To The Eligible Employees

Grant of stock options to eligible employees

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Q3 FY 24 Earnings Conference Call

Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Nine M

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve unaudited financial results for the quarter and nine months ended December 31 2023